ARCHIVES

Broder Issues Clinical Alert on 5-FU Levamisle Survival Advantage for Dukes C Colon Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 38 | October 6, 1989

Download PDF Visit The Full Archive

Related Articles

In Brief: Cowan to Direct Eppley Cancer Center; Nealon Retires From NCI Liaison Office

June 11, 1999

Interferon Interest Zooms; NCI Awarding Production Contracts, Proceeds With Plans For Clinical Trials

March 14, 1980

Treatment research Reports Summarized; New MTX Rescues

May 6, 1977

Two-Week Break Balances RT Palliation, Side Effects

February 26, 2010

Study Suggests Biomarker For Resistance to Tamoxifen

March 25, 2011

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

November 10, 1995